Mayo Clinic and Gentag ink IP collaboration to commercialize biosensors for diabetes, obesity
Mayo Clinic has inked a deal with biosensor developer Gentag that will focus on the needs of patients with diabetes and obesity, according to a statement from the provider. It marks Gentag’s first collaboration with a provider. The terms of the agreement involve Mayo and Gentag working with third parties under license to develop next […]